Kineta Reports First Quarter 2024 Financial Results and Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial and Corporate Activities [Yahoo! Finance]
Kineta Reports First Quarter 2024 Financial Results and Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial and Corporate Activities
Kineta Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 VISTA-101 Clinical Trial
Kineta Reports Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
Kineta Reports Full Year 2023 Financial Results and Provides Corporate Update